Diagnostic laboratory coverage using ICD-10 E28.2
ICD-10-CM code E28.2 can support medical necessity, but it does not automatically guarantee payment for a complete blood count (CBC) or comprehensive metabolic panel (CMP) because coverage depends on documented “reasonable and necessary” diagnostic intent. [1], [2]
Medicare coverage rules for diagnostic laboratory tests
Medicare Part B covers medically necessary diagnostic laboratory tests when ordered by a health care provider. [1]
Medical necessity documentation requirements for lab orders
Medicare requires documentation that the ordered tests are reasonable and necessary for managing the specific condition being treated. [2]
CBC coverage logic for Medicare
A Medicare National Coverage Determination for “Blood Counts” describes CBC coverage as diagnostic evaluation for abnormalities of the blood or bone marrow and lists clinical indications for CBC, including suspected anemia related to abnormal menstrual bleeding and other symptoms or findings. [3]
CMP coverage logic for Medicare
A CMP is generally treated as a diagnostic laboratory test that can be covered when medically necessary and ordered for evaluation of a suspected illness, diagnosis, or complication, with documentation in the medical record supporting the clinical reason for the panel. [1], [2]
Practical implication of using E28.2
E28.2 can be an appropriate diagnosis code when documentation links polycystic ovarian syndrome to the specific clinical reason for CBC (for example, anemia evaluation related to abnormal menstrual bleeding) or for CMP (for example, assessment of suspected metabolic or hepatic or renal complications). [2], [3]
Limitation across payers
Coverage for CBC and CMP is payer- and plan-specific, so commercial insurers can deny tests despite an ICD-10 diagnosis code if medical-necessity documentation and ordering frequency requirements are not met. [1], [2]